MarketPulse

misleading statements

533 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Camping World Faces Class Action Over Inventory Claims and Financial Disclosures

Class action lawsuit filed against Camping World Holdings alleges false inventory management claims and financial misstatements from April 2025 to February 2026.
CWHsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Ultragenyx Hit With Class Action Over Setrusumab Trial Data Misrepresentations

Class action filed against Ultragenyx ($RARE) alleging misrepresented setrusumab trial data. Investors purchasing August 2023-December 2025 may recover damages.
RAREsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Corcept Stock Crashes 50% as FDA Rejection Sparks Securities Lawsuit

Corcept Therapeutics faces securities class action over allegedly misleading statements about relacorilant's FDA approval prospects, triggering 50% stock plunge and $3.6B market cap loss.
CORTsecurities class actionFDA rejection
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Camping World Stock Plummets 25% on Inventory Woes; Class Action Lawsuit Filed

Camping World Holdings faces class action lawsuit over alleged false statements about inventory management. Stock fell 25% after Q3 earnings, then 16% after Q4 results; dividend suspended.
CWHsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Class Action Filed Against Aquestive Therapeutics Over Anaphylm Drug Application Disclosures

Rosen Law Firm files securities class action against $AQST over alleged misleading statements regarding its Anaphylm drug application between June 2025 and January 2026.
AQSTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Major Class Actions Filed Against Navan, Corcept Over Disclosure Failures

Law firm Bragar Eagel & Squire files class action lawsuits against $NAVAN and $COPT alleging material misstatements, citing 60%+ and 50%+ stock declines respectively.
CORTNAVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Major Class Actions Target Nuclear Innovator NuScale and Tech Firm Ostin Over Fraud Allegations

Class action lawsuits filed against $SMR developer NuScale and $OSTN over securities fraud, including $110M scheme and misrepresented nuclear partnerships.
SMROSTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

monday.com Faces Class Action Over Alleged Growth Projection Misstatements

monday.com faces class action lawsuit alleging false growth projections during 2025-2026 period. Stock fell 21% after company abandoned $1.8B 2027 revenue target.
MNDYsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Boston Scientific Faces Class Action Over Electrophysiology Segment Misstatements

Law firm investigates $BSC for allegedly misleading investors about U.S. Electrophysiology growth sustainability and competitive pressures during July 2025-February 2026 period.
BSXclass action lawsuitmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Boston Scientific Faces Securities Lawsuit Over Electrophysiology Market Misrepresentation

Boston Scientific faces class action lawsuit alleging misleading statements about electrophysiology market position, with stock down 17% after missing earnings guidance.
SNOWBSXDRVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Mereo BioPharma Faces Class Action Over Failed Drug Trials and Misleading Statements

Mereo BioPharma faces class action over failed Phase 3 trials and alleged misleading statements. Investor deadline April 6, 2026.
MREOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Ramaco Resources Hit With Class Action Over False Brook Mine Claims

Class action filed against Ramaco Resources ($METC) alleging executives made false statements about Brook Mine development progress, affecting investors from July-October 2025.
METCMETCBMETCIMETCZsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

Corcept Therapeutics Faces Securities Fraud Lawsuit Over Misleading FDA Claims

Schall Law Firm seeks investors in $COPT securities class action, alleging false statements about relacorilant FDA approval prospects between October 2024 and December 2025.
CORTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

PomDoctor Securities Class Action: April 7 Deadline Looms for Defrauded Investors

Rosen Law Firm alerts $POM investors of April 7, 2026 lead plaintiff deadline in securities fraud lawsuit alleging false statements and manipulative trading schemes.
POMsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Class Action Lawsuits Filed Against $POMD and $INO Over Fraud Allegations

Class actions filed against PomDoctor for stock promotion fraud and Inovio for misleading regulatory claims. Inovio stock plunged 24.45% after FDA rejection.
INOPOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Soleno Therapeutics Faces Class Action Over Alleged PWS Drug Safety Misstatements

Class action lawsuit filed against $SLNO alleging false statements about DCCR safety concerns and commercial viability for Prader-Willi syndrome treatment.
SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Snowflake Faces Major Securities Lawsuit Over Misleading Revenue Guidance

Securities class action filed against $SNOW alleging officers made materially misleading statements about revenue growth and 2029 targets, triggering 18% stock decline.
SNOWsecurities fraudstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Enphase Energy Executives Face Personal Liability in Securities Lawsuit Over Disclosure Failures

Enphase Energy CEO and CFO named as defendants in securities class action over alleged misleading statements regarding inventory levels and 25D Credit impact.
ENPHrevenue guidancesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Gene Therapy Giant REGENXBIO Faces Class Action Over RGX-111 Misstatements

Class action lawsuit filed against REGENXBIO alleging false statements about RGX-111 gene therapy. Covers investors from Feb 2022 to Jan 2026; lead plaintiff deadline April 14.
RGNXsecurities fraudclass action lawsuit
BenzingaBenzinga··Business Wire

OLMA Stock Plummets 19.6% Amid Securities Investigation Over Undisclosed Trial Risks

DJS Law Group investigates Olema Pharmaceuticals for potential securities violations following failed Roche trial, triggering sharp stock decline.
OLMAstock declinemisleading statements